Neuroprotective pathways: Lifestyle activity, brain pathology, and cognition in cognitively normal older adults

Neurobiology of Aging

Volumn 35, Issue 8, 2014, Pages 1873-1882

  Wirth, Miranka ^a   Haase, Claudia M ^c   Villeneuve, Sylvia ^a   Vogel, Jacob ^a   Jagust, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Beta amyloid; Cognitive activity; Cognitive aging; Physical activity; PIB PET; White matter lesion

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ADULT; AGED; ARTICLE; BRAIN SIZE; COGNITION; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORTICAL THICKNESS (BRAIN); FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE METABOLISM; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE PROCESSING; LIFESTYLE; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPROTECTION; NORMAL HUMAN; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUESTIONNAIRE; SIGNAL TRANSDUCTION; SOCIAL STATUS; VERY ELDERLY; AGING; ALZHEIMER DISEASE; BRAIN; METABOLISM; MOTOR ACTIVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; COGNITION; FEMALE; HUMANS; LIFE STYLE; MAGNETIC RESONANCE IMAGING; MALE; MOTOR ACTIVITY; POSITRON-EMISSION TOMOGRAPHY; QUESTIONNAIRES;

EID: 84899917989     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.015     Document Type: Article

References (97)

1. Aizenstein H.J., Nebes R.D., Saxton J.A., Price J.C., Mathis C.A., Tsopelas N.D., Ziolko S.K., James J.A., Snitz B.E., Houck P.R., Bi W., Cohen A.D., Lopresti B.J., DeKosky S.T., Halligan E.M., Klunk W.E. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 2008, 65:1509-1517. 10.1001/archneur.65.11.1509.
2. Arenaza-Urquijo E.M., Landeau B., La Joie R., Mevel K., Mezenge F., Perrotin A., Desgranges B., Bartres-Faz D., Eustache F., Chetelat G. Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders. Neuroimage 2013, 83C:450-457. 10.1016/j.neuroimage.2013.06.053.
3. Barnes D.E., Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011, 10:819-828. 10.1016/S1474-4422(11)70072-2.
4. Bentler P.M., Chou C.P. Practical issues in structural modeling. Sociol. Methods Res. 1987, 16:78-117. 10.1177/0049124187016001004.
5. Bero A.W., Yan P., Roh J.H., Cirrito J.R., Stewart F.R., Raichle M.E., Lee J.M., Holtzman D.M. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat. Neurosci. 2011, 14:750-756. 10.1038/nn.2801.
6. Bollen K.A., Long J.S. Testing Structural Equation Models 1993, Sage Publications, Newbury Park.
7. Braak H., Thal D.R., Ghebremedhin E., Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J.Neuropathol. Exp. Neurol. 2011, 70:960-969. 10.1097/NEN.0b013e318232a379.
8. Brody D.L., Magnoni S., Schwetye K.E., Spinner M.L., Esparza T.J., Stocchetti N., Zipfel G.J., Holtzman D.M. Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 2008, 321:1221-1224. 10.1126/science.1161591.
9. Byrne B.M. Structural Equation Modeling with LISREL, PRELIS, and SIMPLIS : Basic Concepts, Applications, and Programming 1998, L. Erlbaum Associates, Mahwah, N.J.
10. Cardenas V.A., Reed B., Chao L.L., Chui H., Sanossian N., Decarli C.C., Mack W., Kramer J., Hodis H.N., Yan M., Buonocore M.H., Carmichael O., Jagust W.J., Weiner M.W. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke 2012, 43:2865-2870. 10.1161/strokeaha.112.659722.
11. Carlson M.C., Helms M.J., Steffens D.C., Burke J.R., Potter G.G., Plassman B.L. Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement. 2008, 4:324-331. 10.1016/j.jalz.2008.07.002.
12. Christensen H., Korten A., Jorm A.F., Henderson A.S., Scott R., Mackinnon A.J. Activity levels and cognitive functioning in an elderly community sample. Age Ageing 1996, 25:72-80.
13. Conover W.J., Iman R.L. Rank transformations as a bridge between parametric and nonparametric statistics. Am. Stat. 1981, 35:124-129. 10.2307/2683975.
14. Conover W.J., Iman R.L. Analysis of covariance using the rank transformation. Biometrics 1982, 38:715-724. 10.2307/2530051.
15. Costa D.A., Cracchiolo J.R., Bachstetter A.D., Hughes T.F., Bales K.R., Paul S.M., Mervis R.F., Arendash G.W., Potter H. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol. Aging 2007, 28:831-844. 10.1016/j.neurobiolaging.2006.04.009.
16. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9:179-194. 10.1006/nimg.1998.0395.
17. de Groot M., Verhaaren B.F., de Boer R., Klein S., Hofman A., van der Lugt A., Ikram M.A., Niessen W.J., Vernooij M.W. Changes in normal-appearing white matter precede development of white matter lesions. Stroke 2013, 44:1037-1042. 10.1161/STROKEAHA.112.680223.
18. DeCarli C., Fletcher E., Ramey V., Harvey D., Jagust W.J. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005, 36:50-55. 10.1161/01.STR.0000150668.58689.f2.
19. Desikan R.S., McEvoy L.K., Thompson W.K., Holland D., Brewer J.B., Aisen P.S., Sperling R.A., Dale A.M. Amyloid-beta-associated clinical decline occurs only in the presence of elevated p-tau. Arch. Neurol. 2012, 69:709-713. Alzhemier's disease neuroimaging initiative. 10.1001/Archneurol.2011.3354.
20. Desikan R.S., Segonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980. 10.1016/j.neuroimage.2006.01.021.
21. Dickerson B.C., Bakkour A., Salat D.H., Feczko E., Pacheco J., Greve D.N., Grodstein F., Wright C.I., Blacker D., Rosas H.D., Sperling R.A., Atri A., Growdon J.H., Hyman B.T., Morris J.C., Fischl B., Buckner R.L. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 2009, 19:497-510. 10.1093/cercor/bhn113.
22. Erickson K.I., Raji C.A., Lopez O.L., Becker J.T., Rosano C., Newman A.B., Gach H.M., Thompson P.M., Ho A.J., Kuller L.H. Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology 2010, 75:1415-1422. 10.1212/WNL.0b013e3181f88359.
23. Erickson K.I., Voss M.W., Prakash R.S., Basak C., Szabo A., Chaddock L., Kim J.S., Heo S., Alves H., White S.M., Wojcicki T.R., Mailey E., Vieira V.J., Martin S.A., Pence B.D., Woods J.A., McAuley E., Kramer A.F. Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. U.S.A 2011, 108:3017-3022. 10.1073/pnas.1015950108.
24. Ewers M., Sperling R.A., Klunk W.E., Weiner M.W., Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci. 2011, 34:430-442. 10.1016/j.tins.2011.05.005.
25. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U.S.A 2000, 97:11050-11055. 10.1073/pnas.200033797.
26. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
27. Fischl B., Sereno M.I., Dale A.M. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999, 9:195-207. 10.1006/nimg.1998.0396.
28. Floel A., Ruscheweyh R., Kruger K., Willemer C., Winter B., Volker K., Lohmann H., Zitzmann M., Mooren F., Breitenstein C., Knecht S. Physical activity and memory functions: are neurotrophins and cerebral gray matter volume the missing link?. Neuroimage 2010, 49:2756-2763. 10.1016/j.neuroimage.2009.10.043.
29. Folstein M., Folstein S., McHugh P. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinicians. J.Psychiatr. Res. 1975, 12:189-198.
30. Friedland R.P., Fritsch T., Smyth K.A., Koss E., Lerner A.J., Chen C.H., Petot G.J., Debanne S.M. Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc. Natl. Acad. Sci. U.S.A 2001, 98:3440-3445. 10.1073/pnas.061002998.
31. Geffken D.F., Cushman M., Burke G.L., Polak J.F., Sakkinen P.A., Tracy R.P. Association between physical activity and markers of inflammation in a healthy elderly population. Am. J. Epidemiol. 2001, 153:242-250.
32. Gold B.T., Kim C., Johnson N.F., Kryscio R.J., Smith C.D. Lifelong bilingualism maintains neural efficiency for cognitive control in aging. J.Neurosci. 2013, 33:387-396. 10.1523/JNEUROSCI.3837-12.2013.
33. Gons R.A., Tuladhar A.M., de Laat K.F., van Norden A.G., van Dijk E.J., Norris D.G., Zwiers M.P., de Leeuw F.E. Physical activity is related to the structural integrity of cerebral white matter. Neurology 2013, 81:971-976. 10.1212/WNL.0b013e3182a43e33.
34. Gow A.J., Bastin M.E., Munoz Maniega S., Valdes Hernandez M.C., Morris Z., Murray C., Royle N.A., Starr J.M., Deary I.J., Wardlaw J.M. Neuroprotective lifestyles and the aging brain: activity, atrophy, and white matter integrity. Neurology 2012, 79:1802-1808. 10.1212/WNL.0b013e3182703fd2.
35. Hauser R.M., Warren J.R. Socioeconomic indexes for occupations: a review, update, and critique. Sociological Methodol. 1997, 27:177-298. 10.1111/1467-9531.271028.
36. Hayes, A.F. 2013. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach.
37. Hayes A.F., Scharkow M. The relative trustworthiness of inferential testsof the indirect effect in statistical mediation analysis: does method really matter?. Psychol. Sci. 2013, 24:1918-1927. 10.1177/0956797613480187.
38. Hedden T., Mormino E.C., Amariglio R.E., Younger A.P., Schultz A.P., Becker J.A., Buckner R.L., Johnson K.A., Sperling R.A., Rentz D.M. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J.Neurosci. 2012, 32:16233-16242. 10.1523/JNEUROSCI.2462-12.2012.
39. Hedden T., Oh H., Younger A.P., Patel T.A. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology 2013, 80:1341-1348. 10.1212/WNL.0b013e31828ab35d.
40. Hedden T., Van Dijk K.R.A., Shire E.H., Sperling R.A., Johnson K.A., Buckner R.L. Failure to modulate attentional control in advanced aging linked to white matter pathology. Cereb. Cortex 2012, 22:1038-1051. 10.1093/Cercor/Bhr172.
41. Herring A., Lewejohann L., Panzer A.L., Donath A., Kroll O., Sachser N., Paulus W., Keyvani K. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms. Neurobiol. Dis. 2011, 42:530-538. 10.1016/J.Nbd.2011.03.007.
42. Hertzog C., Kramer A.F., Wilson R.S., Lindenberger U. Enrichment effects on adult cognitive development: can the functional capacity of older adults be preserved and enhanced?. Psychol. Sci. Public Interest 2008, 9:1-65. 10.1111/j.1539-6053.2009.01034.x.
43. Ho A.J., Raji C.A., Becker J.T., Lopez O.L., Kuller L.H., Hua X., Dinov I.D., Stein J.L., Rosano C., Toga A.W., Thompson P.M. The effects of physical activity, education, and body mass index on the aging brain. Hum. Brain Mapp. 2011, 32:1371-1382. 10.1002/Hbm.21113.
44. Hultsch D.F., Hammer M., Small B.J. Age differences in cognitive performance in later life: relationships to self-reported health and activity life style. J.Gerontol. 1993, 48:P1-P11.
45. Hultsch D.F., Hertzog C., Small B.J., Dixon R.A. Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging?. Psychol. Aging 1999, 14:245-263.
46. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128. 10.1016/S1474-4422(09)70299-6.
47. Jack C.R., Knopman D.S., Weigand S.D., Wiste H.J., Vemuri P., Lowe V., Kantarci K., Gunter J.L., Senjem M.L., Ivnik R.J., Roberts R.O., Rocca W.A., Boeve B.F., Petersen R.C. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann. Neurol. 2012, 71:765-775. 10.1002/Ana.22628.
48. Jagust W.J., Mormino E.C. Lifespan brain activity, beta-amyloid, and Alzheimer's disease. Trends Cogn. Sci. 2011, 15:520-526. 10.1016/j.tics.2011.09.004.
49. Joshi A., Koeppe R.A., Fessler J.A. Reducing between scanner differences in multi-center PET studies. Neuroimage 2009, 46:154-159. 10.1016/j.neuroimage.2009.01.057.
50. Kang J.E., Lim M.M., Bateman R.J., Lee J.J., Smyth L.P., Cirrito J.R., Fujiki N., Nishino S., Holtzman D.M. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007. 10.1126/science.1180962.
51. Kivipelto M., Helkala E.L., Hanninen T., Laakso M.P., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001, 56:1683-1689.
52. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319. 10.1002/ana.20009.
53. Knopman D.S., Jack C.R., Wiste H.J., Weigand S.D., Vemuri P., Lowe V.J., Kantarci K., Gunter J.L., Senjem M.L., Mielke M.M., Roberts R.O., Boeve B.F., Petersen R.C. Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Ann. Neurol. 2013, 73:472-480. 10.1002/ana.23816.
54. Kok E., Haikonen S., Luoto T., Huhtala H., Goebeler S., Haapasalo H., Karhunen P.J. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann. Neurol. 2009, 65:650-657. 10.1002/ana.21696.
55. Kramer A.F., Erickson K.I., Colcombe S.J. Exercise, cognition, and the aging brain. J.Appl. Physiol. 2006, 101:1237-1242. 10.1152/japplphysiol.00500.2006.
56. Landau S.M., Marks S.M., Mormino E.C., Rabinovici G.D., Oh H., O'Neil J.P., Wilson R.S., Jagust W.J. Association of lifetime cognitive engagement and low beta-amyloid deposition. Arch. Neurol. 2012, 69:623-629. 10.1001/archneurol.2011.2748.
57. Launer L.J. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res. Rev. 2002, 1:61-77.
58. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., Lee V.M., Hersh L.B., Sapolsky R.M., Mirnics K., Sisodia S.S. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713. 10.1016/j.cell.2005.01.015.
59. Liang K.Y., Mintun M.A., Fagan A.M., Goate A.M., Bugg J.M., Holtzman D.M., Morris J.C., Head D. Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Ann. Neurol. 2010, 68:311-318. 10.1002/ana.22096.
60. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J.Cereb. Blood Flow Metab. 1996, 16:834-840. 10.1097/00004647-199609000-00008.
61. Lovden M., Bodammer N.C., Kuhn S., Kaufmann J., Schutze H., Tempelmann C., Heinze H.J., Duzel E., Schmiedek F., Lindenberger U. Experience-dependent plasticity of white-matter microstructure extends into old age. Neuropsychologia 2010, 48:3878-3883. 10.1016/j.neuropsychologia.2010.08.026.
62. Maillard P., Carmichael O., Fletcher E., Reed B., Mungas D., DeCarli C. Coevolution of white matter hyperintensities and cognition in the elderly. Neurology 2012, 79:442-448. 10.1212/WNL.0b013e3182617136.
63. Maillard P., Seshadri S., Beiser A., Himali J.J., Au R., Fletcher E., Carmichael O., Wolf P.A., DeCarli C. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol. 2012, 11:1039-1047. 10.1016/S1474-4422(12)70241-7.
64. Marchant N.L., Reed B.R., DeCarli C.S., Madison C.M., Weiner M.W., Chui H.C., Jagust W.J. Cerebrovascular disease, beta-amyloid, and cognition in aging. Neurobiol. Aging 2012, 33:1006.e25-1006.e36. 10.1016/j.neurobiolaging.2011.10.001.
65. Marshall G.A., Donovan N.J., Lorius N., Gidicsin C.M., Maye J., Pepin L.C., Becker J.A., Amariglio R.E., Rentz D.M., Sperling R.A., Johnson K.A. Apathy is associated with increased amyloid burden in mild cognitive impairment. J.Neuropsychiatry Clin. Neurosci. 2013, 25:302-307. 10.1176/appi.neuropsych.12060156.
66. Mintun M.A., Larossa G.N., Sheline Y.I., Dence C.S., Lee S.Y., Mach R.H., Klunk W.E., Mathis C.A., DeKosky S.T., Morris J.C. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67:446-452. 10.1212/01.wnl.0000228230.26044.a4.
67. Mori T., Shimada H., Shinotoh H., Hirano S., Eguchi Y., Yamada M., Fukuhara R., Tanimukai S., Zhang M.R., Kuwabara S., Ueno S.I., Suhara T. Apathy correlates with prefrontal amyloid beta deposition in Alzheimer's disease. J.Neurol. Neurosurg. Psychiatry 2014, 85:449-455. 10.1136/jnnp-2013-306110.
68. Mormino E.C., Brandel M.G., Madison C.M., Rabinovici G.D., Marks S., Baker S.L., Jagust W.J. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage 2012, 59:1152-1160. 10.1016/j.neuroimage.2011.07.098.
69. Mormino E.C., Kluth J.T., Madison C.M., Rabinovici G.D., Baker S.L., Miller B.L., Koeppe R.A., Mathis C.A., Weiner M.W., Jagust W.J. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009, 132(Pt 5):1310-1323. 10.1093/brain/awn320.
70. Newson R.S., Kemps E.B. General lifestyle activities as a predictor of current cognition and cognitive change in older adults: a cross-sectional and longitudinal examination. JGerontol. B Psychol. Sci. Soc. Sci. 2005, 60:P113-P120.
71. Park H.J., Lee J.D., Chun J.W., Seok J.H., Yun M., Oh M.K., Kim J.J. Cortical surface-based analysis of 18F-FDG PET: measured metabolic abnormalities in schizophrenia are affected by cortical structural abnormalities. Neuroimage 2006, 31:1434-1444. 10.1016/j.neuroimage.2006.02.001.
72. Perrotin A., Mormino E.C., Madison C.M., Hayenga A.O., Jagust W.J. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch. Neurol. 2012, 69:223-229. 10.1001/archneurol.2011.666.
73. Pike K.E., Savage G., Villemagne V.L., Ng S., Moss S.A., Maruff P., Mathis C.A., Klunk W.E., Masters C.L., Rowe C.C. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007, 130(Pt 11):2837-2844. 10.1093/brain/awm238.
74. Preacher K.J., Hayes A.F. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav. Res. Methods Instrum. Comput. 2004, 36:717-731.
75. Preacher K.J., Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 2008, 40:879-891.
76. Raji C.A., Lopez O.L., Kuller L.H., Carmichael O.T., Longstreth W.T., Gach H.M., Boardman J., Bernick C.B., Thompson P.M., Becker J.T. White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol. Aging 2012, 33:834.e7-834.e16. 10.1016/j.neurobiolaging.2011.08.010.
77. Rovio S., Spulber G., Nieminen L.J., Niskanen E., Winblad B., Tuomilehto J., Nissinen A., Soininen H., Kivipelto M. The effect of midlife physical activity on structural brain changes in the elderly. Neurobiol. Aging 2010, 31:1927-1936. 10.1016/j.neurobiolaging.2008.10.007.
78. Rucker D.D., Preacher K.J., Tormala Z.L., Petty R.E. Mediation analysis in social psychology: current practices and new recommendations. Soc. Personal Psychol. Compass 2011, 5:359-371. 10.1111/j.1751-9004.2011.00355.x.
79. Salthouse T.A. Mental exercise and mental aging: evaluating the validity of the "use it or lose it" hypothesis. Perspect. Psychol. Sci. 2006, 1:68-87. 10.1111/j.1745-6916.2006.00005.x.
80. Scarmeas N., Luchsinger J.A., Schupf N., Brickman A.M., Cosentino S., Tang M.X., Stern Y. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009, 302:627-637. 10.1001/jama.2009.1144.
81. Schneider J.A., Bennett D.A. Where vascular meets neurodegenerative disease. Stroke 2010, 41(10 Suppl.):S144-S146. 10.1161/STROKEAHA.110.598326.
82. Shrout P.E., Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol. Methods 2002, 7:422-445.
83. Siscovick D.S., Fried L., Mittelmark M., Rutan G., Bild D., O'Leary D.H. Exercise intensity and subclinical cardiovascular disease in the elderly. The Cardiovascular Health Study. Am. J. Epidemiol. 1997, 145:977-986.
84. Smith E.E., Salat D.H., Jeng J., McCreary C.R., Fischl B., Schmahmann J.D., Dickerson B.C., Viswanathan A., Albert M.S., Blacker D., Greenberg S.M. Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology 2011, 76:1492-1499. 10.1212/WNL.0b013e318217e7c8.
85. Sole-Padulles C., Bartres-Faz D., Junque C., Vendrell P., Rami L., Clemente I.C., Bosch B., Villar A., Bargallo N., Jurado M.A., Barrios M., Molinuevo J.L. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2009, 30:1114-1124. 10.1016/j.neurobiolaging.2007.10.008.
86. Takeuchi H., Sekiguchi A., Taki Y., Yokoyama S., Yomogida Y., Komuro N., Yamanouchi T., Suzuki S., Kawashima R. Training of working memory impacts structural connectivity. J.Neurosci. 2010, 30:3297-3303. 10.1523/JNEUROSCI.4611-09.2010.
87. Taylor H.L., Jacobs D.R., Schucker B., Knudsen J., Leon A.S., Debacker G. Aquestionnaire for the assessment of leisure time physical activities. J.Chronic Dis. 1978, 31:741-755.
88. Thies W., Bleiler L., Alzheimer's A. 2013 Alzheimer's disease facts andfigures. Alzheimers Dement. 2013, 9:208-245. 10.1016/j.jalz.2013.02.003.
89. Vemuri P., Lesnick T.G., Przybelski S.A., Knopman D.S., Roberts R.O., Lowe V.J., Kantarci K., Senjem M.L., Gunter J.L., Boeve B.F., Petersen R.C., Jack C.R. Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann. Neurol. 2012, 72:730-738. 10.1002/ana.23665.
90. Voss M.W., Heo S., Prakash R.S., Erickson K.I., Alves H., Chaddock L., Szabo A.N., Mailey E.L., Wojcicki T.R., White S.M., Gothe N., McAuley E., Sutton B.P., Kramer A.F. The influence of aerobic fitness on cerebral white matter integrity and cognitive function in older adults: results of a one-year exercise intervention. Hum. Brain Mapp. 2012, 34:2972-2985. 10.1002/hbm.22119.
91. Wilson R., Barnes L., Bennett D. Assessment of lifetime participation in cognitively stimulating activities. J.Clin. Exp. Neuropsychol. 2003, 25:634-642. 10.1076/jcen.25.5.634.14572.
92. Wilson R.S., Bennett D.A., Bienias J.L., Aggarwal N.T., Mendes De Leon C.F., Morris M.C., Schneider J.A., Evans D.A. Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002, 59:1910-1914.
93. Wilson R.S., Mendes De Leon C.F., Barnes L.L., Schneider J.A., Bienias J.L., Evans D.A., Bennett D.A. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 2002, 287:742-748.
94. Wirth M., Madison C.M., Rabinovici G.D., Oh H., Landau S.M., Jagust W.J. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-amyloid in cognitively normal older individuals. J.Neurosci. 2013, 33:5553-5563. 10.1523/JNEUROSCI.4409-12.2013.
95. Wirth M., Oh H., Mormino E.C., Markley C., Landau S.M., Jagust W.J. The effect of amyloid beta on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement. 2013, 9:687-698.e1. http://dx.doi.org/10.1016/j.jalz.2012.10.012.
96. Wirth M., Villeneuve S., Haase C.M., Madison C.M., Oh H., Landau S.M., Rabinovici G.D., Jagust W.J. Associations between alzheimer diseasebiomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol. 2013, 70:1512-1519. 10.1001/jamaneurol.2013.4013.
97. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., Leirer V.O. Development and validation of a geriatric depression screening scale: a preliminary report. J.Psychiatr. Res. 1982, 17:37-49.